Greater China Managing Partner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Opening Trading Doors Wider-- Beijing Review

Opening Trading Doors Wider-- Beijing Review
bjreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bjreview.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealandCity ofUnited kingdomZhang renyuErnst youngFirst china international import expoNational exhibition centerSouth americanGreater china managing partnerKey accountsGeneral managerSimon electric china

Indian drug manufacturers benefit from Big Pharma interest beyond China

Indian drug manufacturers benefit from Big Pharma interest beyond China
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

United statesPeter deyoungAshish nimgaonkarHelen chenIndian cdmosPiramal pharmaRamesh subramanianTommy erdeiAragen life sciencesSai life sciencesDrug administrationPiramal pharma solutionsGlyscend therapeuticsGreater china managing partnerMordor intelligenceLife sciences

India gains as Big Pharma looks beyond China

Drugmakers are reducing their reliance on Chinese contractors and turning to manufacturers in India for clinical trials and early-stage manufacturing, as tensions with China and concerns over supply chain exposure increase.

United statesCity ofUnited kingdomAndhra pradeshRamesh subramanianCatherine evansAndrew silverRishika sadamTommy erdeiPiramal pharmaPeter deyoungIndian cdmosHelen chenMaggie fickAshish nimgaonkarMichele gershberg

FOCUS -Indian drug manufacturers benefit from Big Pharma interest beyond China

Drugmakers are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing, a move that is benefiting rivals in India, according to.

United statesCity ofUnited kingdomAndhra pradeshHelen chenIndian cdmosRishika sadamTommy erdeiMichele gershbergPiramal pharmaPeter deyoungAshish nimgaonkarRamesh subramanianMaggie fickCatherine evansAndrew silver

Indian drug manufacturers benefit from Big Pharma interest beyond China

Drugmakers are seeking to limit their reliance on Chinese contractors who produce drugs used in clinical trials and early-stage manufacturing, a move that is benefiting rivals in India, according to interviews with 10 industry executives and experts. China has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low cost and speed offered by contract drugmakers there. That is leading some biotech companies to consider using manufacturers in India to produce active pharmaceutical ingredient (API) for clinical trials or other outsourced work.

City ofUnited kingdomAndhra pradeshUnited statesMaggie fickCatherine evansRamesh subramanianRishika sadamIndian cdmosPiramal pharmaAndrew silverMichele gershbergTommy erdeiAshish nimgaonkarHelen chenPeter deyoung